S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Investing

Loeb Reiterates Call for PDLI’s CEO’s Head; Says Company Should Follow MEDI to the Auction Block

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

From 13D Tracker

Large PDL BioPharma (Nasdaq: PDLI) shareholder Third Point LLC, run by Daniel Loeb, confirmed what they called a "very disappointing" response to their recent requests and reiterated its demand that CEO Mark McDade step down, citing his misteps including unnecessary spending on the Company’s corporate headquarters (Loeb called it the Taj Mahal) as well as wasteful R&D and SG&A spending.

Third Point requested that the Company founder and board member Laurence Korn be immediately installed as acting chief executive officer and chairman.

ThirdPoint said PDLI’s Board should act in a similar fashion to MedImmune’s (Nasdaq: MEDI) board, which announced last week that they engaged Goldman Sachs to explore a sale of the Company.

Third Point ended saying, "In sum, we ask the Board to look past personal loyalty to Mr. McDade and think objectively about his performance and about the Board’s duty to shareholders. We are confident that you will come to the conclusion that Mr. McDade must go and that an investment bank should be engaged to explore strategic alternatives expeditiously."

Press Release from Third Point

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Douglas A. McIntyre |

Loeb’s Third Point LLC Raises Stake in PDL BioPharma (PDLI), Wants Four Board Seats, Retain Consulting Firm

From 13D Tracker In an amended 13D filing on PDL BioPharma Inc. (Nasdaq: PDLI), Dan Loeb’s Third Point LLC disclosed…
Jon C. Ogg |

The Plan to Drive Amgen Shares Up Over 70%

Jon OggAmgen Inc. (NASDAQ: AMGN) used to be the king of biotech by size. That was then, and now is…
Disney Plans Get Crushed
Douglas A. McIntyre |

Disney Plans Get Crushed

An investment firm that preys on poor management has set its sites on Disney.
Douglas A. McIntyre |

Dan Loeb: Hedge Fund and Buyout King?

From 13D Tracker
Douglas A. McIntyre |

Loeb’s Third Point LLC Disappointed in Flow Int’l (FLOW) Response to His Call to Sell

From 13D Tracker
Paul Ausick |

Third Point Lowers the Boom on Yahoo (YHOO, EBAY)

As promised, Daniel Loeb and his firm, Third Point LLC, have today sent a letter to Yahoo! Inc. (NASDAQ: YHOO)…
Douglas A. McIntyre |

Nabi Biopharmaceuticals (NABI) and Third Point LLC Reach Agreement

From 13D TrackerYesterday morning, Nabi Biopharmaceuticals (Nasdaq: NABI) and dissident shareholder Third Point LLC announced that they have reached a…
Douglas A. McIntyre |

Loeb’s ThirdPoint LLC Cuts Stake in Ligand (LGND) to 2%, Books Profits

From 13D Tracker In an amended 13D filing on Ligand Pharmaceuticals (Nasdaq: LGND), Daniel Loeb’s ThirdPoint LLC disclosed a 2.01%…
Douglas A. McIntyre |

Yahoo! Shareholder Announces Alternative Board Candidates

Sometimes dissident shareholders threaten proxy fights to get a company to increase its dividend or start a share buyback. Only…

Top Gaining Stocks

Cboe Global Markets
CBOE • Vol: 1,568,143
New Pluto Global
PSKY • Vol: 12,285,993
Seagate Technology
STX • Vol: 7,378,346
Oracle
ORCL • Vol: 26,317,675
Datadog
DDOG • Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ • Vol: 4,367,433
Clorox
CLX • Vol: 13,260,523
Stryker
SYK • Vol: 4,519,455
Mohawk Industries
MHK • Vol: 1,859,865
Amgen
AMGN • Vol: 3,818,618